Finance

Lists
Q3 2026 earnings • released • EPS miss -0.52% • Revenue beat +6.00%
See results
SGHT:NASDAQ
Sight Sciences Inc
$9.76
+0.83%
(+0.080) 1D
$9.76
0.00% (0.00)
After hours
Closed: Nov 5, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGHT...
Open
$9.30
High
$10.30
Low
$9.18
Mkt. cap
537.66M
Avg. vol.
344.48K
Volume
0.00
52-wk high
$10.30
52-wk low
$3.38
EPS
-$0.56
Beta
2.44
Shares outstanding
55.09M
No. of employees
186
Open
$9.30
High
$10.30
Low
$9.18
Mkt. cap
537.66M
Avg. vol.
344.48K
Volume
0.00
52-wk high
$10.30
52-wk low
$3.38
EPS
-$0.56
Beta
2.44
Shares outstanding
55.09M
No. of employees
186
News stories
From web sources and news partners
About Sight Sciences Inc
CEO-
Employees186
Founded2010
Headquarters-
SectorHealth Care
IndustryMedical device
Websitesightsciences.com
Analyst ratings
Based on 5 analysts giving stock ratings to SGHT in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for SGHT in the last 3 months.
Highest
Current $9.76
$14.00 (+43.44%)
Average
$12.00 (+22.95%)
Lowest
$10.00 (+2.46%)
Analyst
Recommendation
Action
Price target
Projected
Date
Frank Takkinen
Lake Street
Buy
Maintained
$14.00
+43.4%
11/05/2026
Thomas Stephan
Stifel Nicolaus
Buy
Reiterated
$10.00
+2.5%
11/05/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
$12.00
+23%
11/05/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$14.00
+43.4%
11/05/2026
Joanne Wuensch
Citi
Hold
Reiterated
$10.00
+2.5%
10/05/2026
Steven Lichtman
William Blair
Buy
Maintained
-
-
08/06/2026
Patrick Wood
UBS
Buy
Maintained
$8.00
-18%
08/06/2026
David Saxon
Needham
Hold
Maintained
-
-
08/06/2026
Adam Maeder
Piper Sandler
Buy
Reiterated
$9.00
-7.8%
08/06/2026
Danielle Antalffy
UBS
Buy
Maintained
$8.00
-18%
08/06/2026
Ryan Meyers
Lake Street
Buy
Reiterated
$12.00
+23%
08/05/2026
Last report
Nov 4, 2026
Fiscal period
Q3 2026
-$0.12 / -$0.12
-0.52%miss
Revenue / Est. (USD)
24.92M / 23.51M
+6.00%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
20.38M
19.70M
23.39M
24.92M
Cost of goods sold
2.60M
2.72M
2.01M
-
Cost of revenue
2.60M
2.72M
2.01M
-
Research and development expenses
2.44M
2.55M
2.51M
2.71M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.02M
21.44M
22.75M
-
Operating expense
21.46M
23.99M
25.26M
27.55M
Total operating expenses
24.05M
26.71M
27.28M
31.05M
Operating income
-3.67M
-7.01M
-3.89M
-6.13M
Other non operating income
-30.00K
-29.00K
82.00K
-51.00K
EBT including unusual items
-4.15M
-12.97M
-4.42M
-
EBT excluding unusual items
-4.15M
-7.57M
-4.42M
-
Income tax expense
8.00K
11.00K
28.00K
11.00K
Effective tax rate
-0.19%
-0.08%
-0.63%
-0.16%
Other operating expenses
-
-
-
-
Net income
-4.16M
-12.98M
-4.45M
-
Net profit margin
-20.42%
-65.89%
-19.01%
-27.32%
Earnings per share
-0.08
-0.24
-0.08
-0.12
Interest and investment income
834.00K
741.00K
678.00K
692.00K
Interest expense
-1.29M
-1.27M
-1.29M
-
Net interest expenses
-455.00K
-527.00K
-612.00K
-620.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.56M
-6.91M
-3.79M
-6.02M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps